Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05829122
Other study ID # XinyuG
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 1, 2020
Est. completion date December 31, 2023

Study information

Verified date March 2023
Source Changzhou Second People's Hospital affiliated with Nanjing Medical University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In this study, patients with various causes of pupillary dilatation were recruited, and medical records and ophthalmology examinations, including slit-lamp examination, visual acuity, best corrected visual acuity, intraocular pressure, pupil diameter, corneal endothelial cell count, fundus examination, and photophobia score, were collected. Those who met the recruitment criteria underwent modified iris cerclage pupilloplasty. The modified iris cerclage pupilloplasty was performed by making four clear corneal incisions, suturing the iris 3-4 times consecutively between each two incisions, completing 360 degrees of iris suturing in sequence, and finally tying the knot intraocularly to complete the iris cerclage.


Recruitment information / eligibility

Status Recruiting
Enrollment 20
Est. completion date December 31, 2023
Est. primary completion date December 1, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - diagnosis of aphakia - permanently dilated pupils - history of phacoemulsification and pars plana vitrectomy surgeries for lens dislocation after blunt trauma Exclusion Criteria: - iris defects - severe diseases such as cyclodialysis cleft, uncontrolled IOP, retinal detachment - poorly controlled systemic diseases such as diabetes and hypertension - corneal endothelial cell counts of <1000/mm2 - <6 months of follow-up

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Sutureless Intrascleral Intraocular Lens Fixation and Modified Iris Cerclage Pupilloplasty
In this study, patients with various causes of pupillary dilatation were recruited, and medical records and ophthalmology examinations, including slit-lamp examination, visual acuity, corrected visual acuity, intraocular pressure, pupil diameter, pupil area, corneal endothelial cell count fundus examination, and photophobia score, were collected. Those who met the recruitment criteria underwent modified iris cerclage. The modified iris cerclage was performed by making four clear corneal incisions, suturing the iris 3-4 times consecutively between each two incisions, completing 360 degrees of iris suturing in sequence, and finally tying the knot intraocularly to complete the iris cerclage.

Locations

Country Name City State
China Preoperatively and 6 Months Postoperatively Changzhou Jiangsu

Sponsors (1)

Lead Sponsor Collaborator
Changzhou Second People's Hospital affiliated with Nanjing Medical University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary best corrected visual acuity logMAR preoperatively
Primary best corrected visual acuity logMAR 6 months postoperatively
Primary intraocular pressure mmHg preoperatively
Primary intraocular pressure mmHg 6 months postoperatively
Primary pupil diameter mm preoperatively
Primary pupil diameter mm 6 months postoperatively
Primary corneal endothelial cell count cell/mm2 preoperatively
Primary corneal endothelial cell count cell/mm2 6 months postoperatively
See also
  Status Clinical Trial Phase
Completed NCT03050697 - Evaluation of the Safety and Performance of the HARMONI® Toric Lens N/A
Terminated NCT00960700 - A Multi Focal Visual Outcome Study Using Different Near Additions N/A
Completed NCT00773266 - Intraocular Position of Secondary Iris-Fixated IOLs in Aphakic Eyes N/A
Completed NCT00838045 - Evaluation of the Safety & Effectiveness of the Bausch & Lomb AKREOS® TL Intraocular Lens Phase 4
Recruiting NCT05796453 - Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix N/A
Completed NCT01230060 - One-Piece Hydrophobic Acrylic Intraocular Lens in Subjects Undergoing Cataract Extraction Phase 3
Completed NCT05481125 - Clareon Toric vs Eyhance Toric N/A
Not yet recruiting NCT04516889 - Evaluating Safety and Efficacy of a Modified Technique of Scleral Fixation Intraocular Lens Implantation N/A
Completed NCT03733730 - Post Approval Study of the AcrySof® IQ ReSTOR® Toric IOLs N/A
Completed NCT04098367 - Clinical Investigation of the AcrySof IQ Vivity Extended Vision Intraocular Lens (IOL) N/A
Completed NCT04528069 - Clinical Investigation of the Visual Outcomes and Safety of a Trifocal Toric IOL in an Asian Population N/A
Completed NCT05852470 - Evaluation of Clareon Vivity/Vivity Toric N/A
Completed NCT01061281 - Evaluation of the Tecnis™ Multifocal and Crystalens™ Accommodating Intraocular Lenses Phase 4
Completed NCT00625313 - Clinical Study of a UV-Absorbing Acrylic Posterior Chamber Intraocular Lens N/A
Completed NCT06389643 - Comparison of Safety and Efficacy of Four-Point Scleral Intraocular Lens Fixation and Yamane Techniques N/A
Completed NCT03316885 - Post-Market Clinical Investigation of the Clareon® IOL N/A
Completed NCT02418871 - Evaluation of the FluidVision Accommodating Intraocular Lens (AIOL) With an Improved Injector System N/A
Completed NCT03054649 - ClarVista HARMONI Toric Trial With Intraoperative Exchange N/A
Withdrawn NCT04800016 - Real-World Study of Vivity Intraocular Lenses (IOLs) N/A
Recruiting NCT06400745 - Clareon PanOptix Pro vs. Clareon PanOptix - Study A N/A